During the past decade, SPSK Nr1 Klinika Hematoo&Transpl.Szpiku conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SPSK Nr1 Klinika Hematoo&Transpl.Szpiku" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "SPSK Nr1 Klinika Hematoo&Transpl.Szpiku" are "Hemophilia A" (3 trials), "Lymphoma, T-Cell, Cutaneous" (2 trials), "Mycosis Fungoides" (2 trials), "Myelodysplastic Syndromes" (2 trials) and "Sezary Syndrome" (2 trials). Many other conditions were trialed in "SPSK Nr1 Klinika Hematoo&Transpl.Szpiku" in a lesser frequency.

Most popular intervention types in "SPSK Nr1 Klinika Hematoo&Transpl.Szpiku" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (2 trials), "ONTAK" (2 trials), "Azacitidine" (1 trials), "Bypassing Agents" (1 trials) and "Durvalumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "SPSK Nr1 Klinika Hematoo&Transpl.Szpiku" are 7 trials for "All" genders.

Currently, there are NaN active trials in "SPSK Nr1 Klinika Hematoo&Transpl.Szpiku". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in SPSK Nr1 Klinika Hematoo&Transpl.Szpiku, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SPSK Nr1 Klinika Hematoo&Transpl.Szpiku, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".